Nav: Home

Can we put a price on healthcare innovation in cancer?

October 28, 2016

Most media attention is awarded to cancer's success stories - new treatment breakthroughs are celebrated as researchers (and journalists) search for an exciting new "cure" for cancer. But what happens after these innovations hit the news? And who is going to buy them?

The newest drugs are frequently the most costly, and healthcare systems are already struggling. Where is the money going? And is there evidence that the money spent on innovation actually benefits cancer patients?

That's why the latest Special Issue from ecancermedicalscience tackles the overlooked topic of health economics in cancer care. We've collected five new papers ranging from the policy level to the personal.

The papers have been curated by expert Guest Editor Prof Wim van Harten of the Netherlands Cancer Institute, Amsterdam, the Netherlands.

"The pipeline of new drugs is impressive, and health systems are already struggling with the fast-growing list of extremely high-priced treatments on the market," says Prof Harten.

"This will inevitably put further strain on healthcare budgets - some politicians state that they are already nearing the maximum that Western countries can bear."

The papers address the questions raised above, and offer solutions - including some methods to assess the "value" of healthcare innovation, allowing policymakers to make informed decisions about where funds should be spent.

But it's not just policy that needs to change - these papers address the cost of healthcare at the patient interface as well.

"When physicians prescribe cancer treatment, we should consider if we would make the same decision if we were paying for the treatment ourselves," says contributing author Dr Guy Storme of the Universitair Ziekenhuis Brussel, Brussels, Belgium. "I think this would lead to a positive change in mentality - one of my colleagues has already changed his clinical practice in this way."

Dr Storme adds, "I would like the public to understand the real benefit and cost of each treatment, because most never see the cost breakdowns - and the added value of the individual treatment!"

For those who haven't previously considered the costs of cancer care, the Special Issue will provide a thorough review of the subject.
-end-
Read the articles here: http://ecancer.org/special-issues/13-health-economics-in-cancer-research-and-care.php?full=1

ecancermedicalscience

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...